World Journal of Surgery

, Volume 31, Issue 5, pp 1002–1004

From Genetic Testing to the Operating Room

Invited Commentary


  1. 1.
    Lerman C, Shields AE. Genetic testing for cancer susceptibility: the promise and the pitfalls. Nature Rev Cancer 2004;4:235–241CrossRefGoogle Scholar
  2. 2.
    Gimm O, Ukkat J, Niederle BE, Weber T, Thanh PN, Brauckhoff M, Niederle B, Dralle H. Timing and extent of surgery in patients with familial medullary carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634. World J Surg 2004;28:1312CrossRefPubMedGoogle Scholar
  3. 3.
    Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JF, et al. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 1994;220:237–247CrossRefPubMedGoogle Scholar
  4. 4.
    Skinner MA, Moley JF, Dilley WG, Owzar K, DeBenedetti MK, Wells SA Jr. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 2005;353:1105–1113CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2007

Authors and Affiliations

  1. 1.Department of Surgery, Division of Surgical OncologyScott & White Hospital and Clinic, Texas A&M University System Health Science Center College of MedicineTempleUSA

Personalised recommendations